Shawn Zhang

Company: Ambrx, a Johnson & Johnson Company

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Contextualizing the Ongoing Growth & Success of the ADC Field & Envisioning the Best Route Forward for ADC Innovation 8:00 am

Reflecting on the past and envisioning the future of the ADC field: spanning upcoming approvals, exciting targets, novel linker-payloads, conjugation technologies, and combination therapies Deep-diving into recent clinical trials – what ADCs have broken the perceived clinical expectations for success? Debating rationale of going after new targets and using novel payloads against iteratively improving the…Read more

day: Day One AM